Webinars & Presentations High Efficiency Cell Engineering Discussion at Harvard University

Join us for a Discussion on High Efficiency Cell Engineering

Thursday, July 11, 2024
1:30 - 2:30 pm (ET)

In-person
Harvard School of Public Health
Duraisingh Lab

About the event

Are you involved in cell engineering research and eager to bridge the gap from the lab to real-world clinical applications?

We invite you to an informative presentation and discussion on Scalable Cell Engineering from 1:30 to 2:30 pm (ET) PM hosted by the Duraisingh Lab.

Our MaxCyte presenters will demonstrate how customers use the MaxCyte scalable transfection platform to edit primary cells, stem cells, and other hard-to-transfect cell lines while maintaining high efficiency and viability regardless of application.

RSVP to the in-person seminar by filling out the form. This will help us tailor the discussion/presentation to be more specific to your cell type(s) and application(s).

Lunch on us: we value your time, and to keep the focus on learning, we're providing a complimentary lunch for all attendees.

If you have any questions related to this event, please contact Lunch on us: we value your time, and to keep the focus on learning, we're providing a complimentary lunch for all attendees. If you have any questions related to this event, please contact Jess Keeley.

Hosts

Leif Anderson

Senior Field Application Scientist
MaxCyte, Inc.

Leif Anderson is a Senior Field Application Scientist at MaxCyte. Leif is a trained biomedical engineer with years of experience working with primary cells, including iPSC’s at the Salk Institute and hematopoietic stem cells at UC Davis. Leif’s professional experience prior to joining MaxCyte includes supporting product development and commercialization of gene therapy products at LUMICKS, Nanoview Biosciences, and Unchained Labs.

Jess Keeley

Business Manager
MaxCyte, Inc.

Jess holds a degree in Biology from the University of Pittsburgh and has built a robust career in biotechnology. With roles at renowned companies such as Thermo Fisher, Biotage, and MaxCyte, he has extensively supported both industry and academic research labs in their cell therapy, gene therapy, and drug discovery workflows. Currently, Jess serves as the Strategic Business Manager for MaxCyte, overseeing the Northeast US and Eastern Canada regions.

RSVP

Please fill out this form to help us tailor the discussion/presentation to be more specific to your cell type(s) and application(s).

Join us for a Discussion on High Efficiency Cell Engineering